We collect information on diseases, related clinical trials and early access programs around the globe and share it through an open database. The database currently includes information about 325288 clinical trials, as well as 395 early access programs. By including as much information as possible in the database, we aim to assist physicians and their patients in their search for accurate and uniform information. 

We have an in-house team of medical, regulatory and legal experts who respond to information requests. Physicians can request more information about the drugs in development on our platform. By providing medical, regulatory, legal and pricing data to physicians on request, we aim to assist physicians and patients in making a well-informed and sound decision about treatment options.

We facilitate access to drugs in development once a physician and a patient, have decided to start treatment. Our platform currently offers treatment options for a growing number of indications. By taking care of the often complex and time consuming process of receiving approval from regulatory authorities, manufacturers and healthcare insurers, we aim to ease the burden on physicians and their patients by fulfilling their request as quickly as possible.

In addition to the information available in our open database, we are currently in the process of developing a comprehensive approach to collecting real world treatment data about patients that are prescribed a drug through our platform. These will be collected in cooperation with treating physicians through observational trials. By collecting and sharing real world treatment data, we aim to enhance data-driven decision-making for medical treatments and support rational pharmacotherapy.